Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 2.2% | n/a |
ROCE | 4.7% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.8 | n/a |
Pr/Book | 6.1 |
Latest | F'cast | |
---|---|---|
Revenue | 32.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-23 | 43.92 | (7.65) | (0.10)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 58.36 | (0.94) | (0.02)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
2024 Final Results | 28-Apr-2025 | 07:00 | RNS |
TWO2® in NHS supply chain framework agreement | 22-Apr-2025 | 07:00 | RNS |
Notification of Major Holdings | 09-Apr-2025 | 10:06 | RNS |
No recent information was found.
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 75.00p |
Change Today | -1.00p |
% Change | -1.32 % |
52 Week High | 136.00 |
52 Week Low | 75.00 |
Volume | 63,731 |
Shares Issued | 106.36m |
Market Cap | £79.77m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:28 | 25,000 @ 78.50p |
16:36 | 5,500 @ 75.00p |
16:35 | 9,000 @ 75.00p |
16:35 | 6,500 @ 75.00p |
16:35 | 2,500 @ 75.00p |
CEO | Michael Stephen Griffiths |
COO | Anthony Matthew Moffatt |
CFO | Jayesh Pankhania |
You are here: research